Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain

P Gomes1, E Giralt, D Andreu

  • 1Department of Organic Chemistry, University of Barcelona, Martí i Franquès 1, E-08028, Barcelona, Spain.

Vaccine
|May 12, 2001
PubMed

Insights

Foot-and-mouth disease virus (FMDV) mutations in the GH loop impact peptide antigenicity. Cyclization can modulate antigenicity, suggesting conformation is key for continuous antigenic sites.

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • Foot-and-mouth disease virus (FMDV) isolate C(1)-Barcelona (C-S30) exhibits four amino acid substitutions in its immunodominant GH loop compared to reference strain C-S8c1.
  • One mutation (147Leu-->Val) in C-S30 is known to impair antibody recognition, yet this isolate showed similar reactivity with a specific neutralizing monoclonal antibody (mAb) 4C4 as reference strains.

Purpose of the Study:

  • To investigate the structural basis for the unexpected antibody reactivity of FMDV isolate C-S30.
  • To evaluate the impact of linear versus cyclic peptide conformations on antigenicity using surface plasmon resonance (SPR) and 2D-1H NMR.

Main Methods:

  • Comparative analysis of FMDV GH loop sequences.
  • Structural studies using X-ray crystallography of peptide-mAb complexes.
  • Kinetic analysis of peptide-mAb interactions via surface plasmon resonance (SPR).
  • Conformational analysis using 2D proton nuclear magnetic resonance (2D-1H NMR).

Main Results:

  • Fifteen-residue peptides mimicking the GH loops of C-S30 and C-S8c1 adopted similar quasi-circular conformations in complexes with mAb 4C4.
  • SPR analysis revealed that linear C-S30 peptides were less antigenic in solution than C-S8c1 and C1-Brescia peptides.
  • Cyclization of peptides was explored as a method to modulate antigenicity in solution.

Conclusions:

  • Peptide conformation plays a significant role in antigenicity, even for continuous antigenic sites.
  • Structural similarities in peptide-mAb complexes do not fully explain observed differences in solution-phase antigenicity.
  • Modulating peptide conformation, potentially through cyclization, can influence antigenicity in solution.